Periodic Reporting for period 1 - Doraya (Doraya is an innovative catheter device for treating patients resistant to diuretics with Acute Heart Failure (AHF) condition.)
Periodo di rendicontazione: 2019-01-01 al 2019-04-30
Fluid decongestion is the key treatment of AHF, and AHF patients are treated with diuretics. Diuretics are a family of drugs designed to increase urine output, thus removing excess fluids and attempting to dry the patient. However, 20-30% of AHF admitted patients suffer from poor response to diuretics, preventing their proper and rapid fluid removal. Because currently there are no viable therapies for these patients, they have increased mortality, longer and costly hospital stays, and higher re-admission rates.
To solve these problems, Revamp Medical has developed Doraya™, an innovative catheter-based device designed for AHF patients who suffer from poor response to diuretics. Doraya™ helps to relieve fluid congestion by improving diuretic efficiency. This temporary catheter will expedite treatment by offering cardiologists a completely new approach to manage their admitted patients.